Mission Bio is the developer of the Tapestri Platform which is a single-cell multi-omics platform enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. This company was founded in 2014 by Adam Abate, Adam Sciambi, Charlie Silver and Dennis Eastburn and is headquartered in San Francisco, CA. Mission Bio helps researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine.

Register for Details

For more details on financing and valuation for Mission Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Mission Bio

Forge green plus iconForge green minus icon

What is Mission Bio's IPO price?

The IPO price for Mission Bio will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Mission Bio?

Mission Bio is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Mission Bio shares pre-IPO?

If you own Mission Bio pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Mission Bio a publicly traded company?

Mission Bio is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Mission Bio's funding to date?

Mission Bio has raised $216.72MM to date.
Forge green plus iconForge green minus icon

When was Mission Bio founded?

Mission Bio was founded in 2014.

Who are Mission Bio's major investors?

Mayfield Fund
Cota Capital
Novo Holdings
Agilent Technologies

Mission Bio Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
5/5/2022 Series D $100MM raised $XXX.XX $XXX.XX
8/13/2020 Series C $72.13MM raised $XXX.XX $XXX.XX
12/13/2018 Series B $30.07MM raised $XXX.XX $XXX.XX
10/17/2017 Series A $14.52MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 19, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.